M. Martín

Renal Cell Carcinoma Associated With Xp11.2 Translocation/TFE3 Gene-fusion: A Long Response to mammalian target of rapamycin (mTOR) Inhibitors.

O. Fernández, R. E. Cornejo, M. Martín, 2018 .

Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk

D. Lambrechts, A. González-Neira, G. Pita, 2023, bioRxiv.

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib

M. Redrado, A. Calvo, J. Capdevila, 2018, Oncotarget.

Intravenous and Oral Magnesium Supplementations in the Prophylaxis of Cisplatin‐Induced Hypomagnesemia

E. Díaz-Rubio, A. Casado, J. Sastre, 1992, American journal of clinical oncology.

Quantifying Clinical Utility of Adjuvant Abemaciclib in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy-Reply.

S. Johnston, M. Martín, R. Wei, 2022, JAMA oncology.